2015
DOI: 10.1016/j.ejphar.2014.10.007
|View full text |Cite
|
Sign up to set email alerts
|

The kallikrein system in retinal damage/protection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…Carbazochrome sodium sulfonate hydrate and kallidinogenase are administered for minor retinal hemorrhage. [ 13 ] The retinal hemorrhage in the present patient was sufficiently minor to require only observation after withdrawing the regorafenib. In cases of vascular leakage, intravitreal injection of anti-VEGF antibody is considered.…”
Section: Discussionmentioning
confidence: 75%
“…Carbazochrome sodium sulfonate hydrate and kallidinogenase are administered for minor retinal hemorrhage. [ 13 ] The retinal hemorrhage in the present patient was sufficiently minor to require only observation after withdrawing the regorafenib. In cases of vascular leakage, intravitreal injection of anti-VEGF antibody is considered.…”
Section: Discussionmentioning
confidence: 75%
“…Although selective inhibition of B1R could potentially provide some protective effect for retinal dysfunction in DR, this approach would not address the potential contributions of B2R or effects mediated by PKal substrates other than HK (18,29). However, the blockade of PKal could reduce the proinflammatory effects of the intravitreal KKS while preserving the potential beneficial ocular effects of BK generated by tissue kallikrein (Klk1) (48). …”
Section: Discussionmentioning
confidence: 99%
“…Our previous study also showed that the expression of vascular endothelial growth factor (VEGF) significantly declined in SHR retinal layers following the increase of blood pressure, suggesting a mechanism responsible for the developmental disabilities of retinal vascularity (Chan et al, ). VEGF can be cleaved by tissue‐derived kallikrein, so the latter has an effect on the disease involving VEGF production (Masuda et al, ). So far, research is still lacking on the rat retinal vascular pattern changes caused by chronic ischemia following the BCCAO procedure.…”
Section: Discussionmentioning
confidence: 99%